Vaping was supposed to be the way out. For millions of people, it became its own trap. Here's how to actually get free.
If you started vaping to quit cigarettes, you're not alone. If you started because it seemed safer, or just at parties — you're not alone either. And if you've tried to quit vaping and found it harder than expected, that's not a personal failure. That's nicotine.
Modern vapes deliver nicotine faster and in higher concentrations than cigarettes ever did. A single Elf Bar can contain the nicotine equivalent of 20-50 cigarettes (based on total nicotine content, delivery rates differ by product).es. No lighter, no smell, fits in your pocket. The result: easy to use constantly, extremely hard to stop.
With a cigarette, there's a natural stopping point. With a vape, there's no end. Many people hit their devices 200+ times a day without realizing it. That level of use creates a deeper physical dependency than most cigarette smokers ever developed.
Your brain has adapted to that nicotine. It now depends on it to regulate mood, focus, and stress. When you stop, those systems go haywire — hence the anxiety, irritability, and the sense that something is just wrong that follows you through the first days without it. Willpower can't override that. It's not a character issue. It's biology.
Switching to a lower-nicotine vape. Most people compensate by vaping more frequently. Same or greater total intake, delivery mechanism completely intact.
Cutting down gradually without a plan. Tapering works in theory. In practice, one bad day collapses whatever progress has been made.
Cold turkey. 3-5% success rate at one year for smoking (Gonzales et al., JAMA 2006). For vaping, unassisted quit rates may be even lower — partly because vapers often develop higher daily nicotine intake than cigarette smokers.
Varenicline is the FDA-approved medication with the strongest evidence for nicotine cessation. Emerging evidence supports its use for vaping as well — a 2025 JAMA study found 51% of young vapers quit at 12 weeks. Most people notice a meaningful reduction in cravings within the first week. Most people notice a meaningful reduction in cravings within the first week.
"You don't have to white-knuckle this. There's medicine that works. The only step left is starting."
A 2025 randomized clinical trial from Mass General Brigham (Evins et al., JAMA 2025) studied varenicline in young adult vapers. The result: 51% quit rate at 12 weeks, compared with 14% on placebo plus counseling and text support. Varenicline is FDA-approved for smoking cessation; use for vaping is reviewed by a physician and may be considered where appropriate.
Study enrolled daily vapers ages 16–25 who did not regularly smoke tobacco. Respiro is for adults 18+.
$75 consultation. Physician review within 24 hours. Varenicline shipped to your door. $75 consultation, satisfaction guaranteed.
Get Early Access, 60 Seconds →